Floatz logo

Gallium-68 Labelled Fap-2286

Myocardial Fibrosis

Thomas HoperadiopharmaceuticalPhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Myocardial Fibrosis cohort.

Asset / SponsorPhaseRating
Enalapril
InCor Heart Institute
Phase 3B
FLUDEOXYGLUCOSE
Thomas Hope
Phase 1CC
PREDNISONE TABLETS
Weill Medical College of Cornell University
Phase 1CC
Losartan
Massachusetts General Hospital
Early Phase 1CC
Aavrh.10Hfxn, Serotype Rh.10 Adeno-Associated Virus Gene Transfer Vector Expressing The Cdna Coding For Human Fxn
Weill Medical College of Cornell University
Phase 1CC
Henagliflozin
RenJi Hospital
N/AD
Metformin
RenJi Hospital
N/AD
Letrozole
RenJi Hospital
N/AD

Same molecule, other indications

Gallium-68 Labelled Fap-2286 is also rated in:

breast cancerDormant
CCC
Indicative ·
53 / 100
View asset →
fibrotic liver diseaseDormant
CC
Indicative ·
46 / 100
View asset →
pulmonary fibrosisDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →